Jang J, Ko K, Zhang J, Jun S, Park J
bioRxiv. 2025; .
PMID: 40060545
PMC: 11888434.
DOI: 10.1101/2025.02.26.637920.
Zahoor A, Khazer R, Mehraj I, Gani U, Fayaz F, Khanday F
Funct Integr Genomics. 2025; 25(1):50.
PMID: 40024973
DOI: 10.1007/s10142-025-01552-x.
Nam C, Huang G, Zheng Y, Zhao H, Pan Y, Hu B
J Exp Med. 2025; 222(4).
PMID: 39964485
PMC: 11834937.
DOI: 10.1084/jem.20240758.
Zhou R, Tang X, Wang Y
Nat Rev Cancer. 2024; 24(12):850-866.
PMID: 39433978
DOI: 10.1038/s41568-024-00754-y.
Min Q, Zhang M, Lin D, Zhang W, Li X, Zhao L
Med Rev (2021). 2024; 4(3):244-256.
PMID: 38919397
PMC: 11195426.
DOI: 10.1515/mr-2024-0008.
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets.
Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen Y
Signal Transduct Target Ther. 2024; 9(1):149.
PMID: 38890350
PMC: 11189549.
DOI: 10.1038/s41392-024-01848-7.
Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma.
Zhao Y, Zhao H, Zhao M, Yu Y, Qi X, Wang J
World J Gastroenterol. 2024; 30(20):2638-2656.
PMID: 38855150
PMC: 11154680.
DOI: 10.3748/wjg.v30.i20.2638.
Immune-tumor interaction dictates spatially directed evolution of esophageal squamous cell carcinoma.
Zhou Y, Mo S, Cui H, Sun R, Zhang W, Zhuang X
Natl Sci Rev. 2024; 11(5):nwae150.
PMID: 38803565
PMC: 11129594.
DOI: 10.1093/nsr/nwae150.
Single Nucleotide Polymorphisms (SNPs) in the Shadows: Uncovering their Function in Non-Coding Region of Esophageal Cancer.
Saikia S, Postwala H, Athilingam V, Anandan A, Padma V, Kalita P
Curr Pharm Biotechnol. 2024; 25(15):1915-1938.
PMID: 38310451
DOI: 10.2174/0113892010265004231116092802.
Absence of Lugol staining indicates initiation of esophageal squamous cell carcinoma: A combined genomic and epidemiologic study.
Liu Z, Liu M, Liu Y, Zhou R, Abliz A, Yuan W
Cell Rep Med. 2023; 4(9):101168.
PMID: 37625408
PMC: 10518598.
DOI: 10.1016/j.xcrm.2023.101168.
Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer.
Liu X, Zhao S, Wang K, Zhou L, Jiang M, Gao Y
Nat Commun. 2023; 14(1):4779.
PMID: 37553345
PMC: 10409784.
DOI: 10.1038/s41467-023-40343-5.
Interactions of piRNAs with the mRNA of Candidate Genes in Esophageal Squamous Cell Carcinoma.
Rakhmetullina A, Akimniyazova A, Niyazova T, Pyrkova A, Tauassarova M, Ivashchenko A
Curr Issues Mol Biol. 2023; 45(7):6140-6153.
PMID: 37504303
PMC: 10378052.
DOI: 10.3390/cimb45070387.
Exploring cell competition for the prevention and therapy of esophageal squamous cell carcinoma.
Knapp K, Verchio V, Coburn-Flynn O, Li Y, Xiong Z, Morrison J
Biochem Pharmacol. 2023; 214:115639.
PMID: 37290594
PMC: 10528900.
DOI: 10.1016/j.bcp.2023.115639.
RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis.
Chen L, Zhang W, Chen D, Yang Q, Sun S, Dai Z
Signal Transduct Target Ther. 2023; 8(1):159.
PMID: 37080995
PMC: 10119322.
DOI: 10.1038/s41392-023-01367-x.
Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma.
Ooki A, Osumi H, Chin K, Watanabe M, Yamaguchi K
Ther Adv Med Oncol. 2023; 15:17588359221138377.
PMID: 36872946
PMC: 9978325.
DOI: 10.1177/17588359221138377.
Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing.
Cui S, McGranahan N, Gao J, Chen P, Jiang W, Yang L
Nat Commun. 2023; 14(1):892.
PMID: 36807354
PMC: 9938262.
DOI: 10.1038/s41467-023-36558-1.
Analysis of genomic and immune intratumor heterogeneity in linitis plastica via multiregional exome and T-cell receptor sequencing.
Huang J, Zhao G, Peng Q, Yi X, Ji L, Li J
Mol Oncol. 2023; 17(8):1531-1544.
PMID: 36703611
PMC: 10399711.
DOI: 10.1002/1878-0261.13381.
The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies.
Testa U, Castelli G, Pelosi E
Curr Oncol. 2023; 30(1):610-640.
PMID: 36661697
PMC: 9858483.
DOI: 10.3390/curroncol30010048.
SOX2OT lncRNA Inhibition Suppresses the Stemness Characteristics of Esophageal Tumorspheres.
Haghi B, Jazi M, Khosravi A, Jafari S, Asadi J
Noncoding RNA. 2022; 8(6).
PMID: 36548179
PMC: 9782980.
DOI: 10.3390/ncrna8060080.
Gallbladder adenocarcinomas undergo subclonal diversification and selection from precancerous lesions to metastatic tumors.
Kang M, Na H, Ahn S, Kim J, Lee S, Ahn S
Elife. 2022; 11.
PMID: 36476508
PMC: 9771369.
DOI: 10.7554/eLife.78636.